HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Ciprofloxacin plus metronidazole

WITHDRAWN · PHASE4 · Acute Uncomplicated Diverticulitis

Study was never approved by the institutional review board.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.